Sab M, Pallis K, Solmi M, Crippa A, Sentissi O, Kaiser S
The worry-symptom feedback loop If youre prone to anxiety, you might find yourself hyper-aware of any changes after starting Wegovy
Talk to your doctor before starting a new diet and exercise plan
2.5 mg/mL concentration chart This is the most widely prescribed compounded concentration according to pharmacy dispensing data
Semaglutide has been associated with an increased risk of gallbladder-related conditions, such as cholelithiasis, particularly in the context of rapid weight loss. There have also been rare reports of pancreatitis with GLP-1 receptor agonists, making it important to monitor patients with a history of pancreatic disease. Furthermore, semaglutide carries a boxed warning (region-dependent) regarding the potential risk of medullary thyroid carcinoma (MTC), based on findings from animal studies
Since Oral Wegovy is FDA-approved for chronic weight management, many insurance plans may offer coverage, though prior authorization or proof of medical necessity may be required
